Editor Profile
Chen-Hsiung Yeh
University/Organization: CirculoGene
Country: United States
Biography
Dr. Chen-Hsiung Yeh received his Ph.D. in Microbiology and Molecular Genetics from Rutgers University, and completed his post-doctoral training at Washington University School of Medicine at St. Louis. He has over 20 years of experience in both biotech pharmaceutical and clinical diagnostics (Rx & Dx) industries. Currently, he is co-founder and Chief Scientific Officer at CirculoGene.
He has held senior management positions in various companies including Vice President of Molecular Testing at Atherotech Diagnostics Lab; General Manager at Response Genetics; Scientific Director at Quest Diagnostics; and Principal Investigator at Pfizer. His expertise and experience includes drug discovery, molecular diagnostics, and advanced technology. He serves on the Editorial Board of several journals and is the author and inventor of over 50 publications and patents.
Research Interest
His research interests are Cancer Biomarker Discovery; Noninvasive Cancer Early Detection; Diagnosis and Prognosis; Liquid Biopsy; Circulating Cell-free DNA/RNA/miRNA; Next-generation Sequencing; Droplet Digital PCR
Scientia Ricerca is licensed and content of this site is available under a Creative Commons Attribution 4.0 International License.